Buck Wealth Strategies’s Sinovac Biotech, Ltd SVA Stock Holding History

Buck Wealth Strategies’s Portfolio SVA Stock Details SVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Buy	+7	New	–	﹤0.01%	1173

Other funds holding SVA

NAH

Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return

Buck Wealth Strategies's SVA Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Sinovac Biotech, Ltd (SVA) in Q2 2026: 7 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1173 among its holdings.

11 funds tracked by Wall St. Rank hold SVA as of Q2 2026.

Buck Wealth Strategies held 7 shares of Sinovac Biotech, Ltd worth $0 as of Q2 2026.
Sinovac Biotech, Ltd was a new Buck Wealth Strategies position in Q2 2026.
Sinovac Biotech, Ltd made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #1173 holding.
11 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.